Guidance Issued for Use of Metformin to Prevent Antipsychotic-Induced Weight Gain
By Elana Gotkine HealthDay Reporter
MONDAY, Dec. 30, 2024 -- In a guideline published online Dec. 9 in Schizophrenia Bulletin, recommendations are presented for the use of metformin to prevent antipsychotic-induced weight gain (AIWG).
Aoife Carolan, from Saint John of God Hospital in Dublin, and colleagues developed a guideline for use of metformin for prevention of AIWG, following the Appraisal of Guidelines for Research and Evaluation II instrument (AGREE II).
The authors note that the only pharmacological instrument that has demonstrated efficacy for preventing AIWG is metformin. Compared with controls, co-commencement with antipsychotic medications can reduce weight gain by 4.03 kg. The guideline for metformin use was developed for co-commencement with an antipsychotic or commencement if certain criteria are met. Strong recommendations include co-commencement of metformin with medium-risk antipsychotics in the presence of one or more cardiometabolic risk factors or in those aged 10 to 25 years, as well as commencement of metformin with any antipsychotic if a >3 percent increase in baseline body weight occurs during the first year of treatment.
"This is the first published evidence-based guideline using the AGREE II framework and GRADE methods for the use of metformin to prevent AIWG incorporating recommendations for co-commencement," the authors write. "Implementation and evaluation of the guideline will be supported by a shared decision-making package and assessment of barriers and facilitators to implementation."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted December 2024
Read this next
Preemies' Early-Life Medical Risk Tied to Worse Health at Age 35
FRIDAY, Aug. 1, 2025 -- Higher early-life medical risk among preterm infants is associated with increased occurrence of mental health disorders, cardiometabolic issues, and body...
Polygenic Scores for BMI Can Improve Prediction of Future Obesity
THURSDAY, July 31, 2025 -- Polygenic scores (PGSs) for body mass index (BMI) can improve obesity prediction, according to a study published online July 21 in Nature...
Prediabetes Risk Doubled for Asian, Pacific Islander Teens With Overweight, Obesity
TUESDAY, July 29, 2025 -- Among adolescents with overweight or obesity, prediabetes is more than twice as common in Asian and Pacific Islander (Asian/PI) adolescents than in White...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.